Highlights
NASDAQ: ALIM       Alimera Sciences Inc
Last Price Today's Change   Day's Range   Trading Volume
4.75   +0.174 (3.80%)  4.47 - 5.20  96,900

Overview

 
Avg Volume (4 weeks):1,264,215
4 Weeks Range:0.197 - 5.20
4 Weeks Price Volatility (%):
91.01%
52 Weeks Range:0.197 - 5.20
52 Weeks Price Volatility (%):
91.01%
Average Price Target: 2.00
Price Target Upside/Downside: -2.75

Headlines



No recent Headlines for this stock.


Business Background

Alimera Sciences Inc is a pharmaceutical company. It specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. The product portfolio of the company includes ILUVIEN, which is developed to treat diabetic macular edema. In addition, to the activities related to the development of ILUVIEN, the group is also researching the safety and effectiveness of NADPH (Nicotinamide Adenine Dinucleotide Phosphate) oxidase inhibitors. Geographically it operates through the region of US and also it has its presence in the international market.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers